Table 1

Primary care consultations and antibiotic prescribing proportions per consultation in adult men and women (aged 19–64 years) with and without comorbidity for 12 different conditions. Only consultations from patients’ primary registered practices are included.

Number of consultations (% of total)F:M consultation
ratio
Proportion of patients receiving prescription when consulting (95% CI)Relative risk of receiving antibiotic prescription when consulting as female (95% CI) (P value)
WomenMenWomenMen
Acne25 676 (74)8864 (26)2.9041% (40% to 41%)60% (59% to 61%)0.67 (0.66 to 0.69) (<0.001)
Acne with comorbidity2344 (66)1185 (34)1.9840% (38% to 42%)55% (52% to 58%)0.73 (0.68 to 0.78) (<0.001)
Bronchitis7085 (61)4584 (39)1.5583% (83% to 84%)84% (83% to 86%)0.99 (0.97 to 1.00) (0.14)
Bronchitis with comorbidity3101 (60)2065 (40)1.5087% (86% to 89%)89% (88% to 91%)0.98 (0.96 to 1.00) (0.03)
COPD3274 (59)2271 (41)1.4476% (74% to 78%)75% (73% to 77%)1.02 (0.99 to 1.05) (0.25)
COPD with non-respiratory comorbidity1287 (56)1029 (44)1.2573% (70% to 76%)70% (69% to 72%)1.06 (1.01 to 1.11) (0.02)
Cough158 614 (61)103 058 (39)1.5448% (48% to 49%)48% (48% to 48%)1.01 (1.00 to 1.02) (0.02)
Cough with comorbidity68 353 (60)46 210 (40)1.4858% (57% to 58%)56% (56% to 57%)1.03 (1.02 to 1.04) (<0.001)
Gastroenteritis41 870 (58)30 810 (42)1.366% (6% to 6%)6% (6%–6%)1.01 (0.96 to 1.08) (0.65)
Gastroenteritis with comorbidity12 184 (57)9216 (43)1.328% (7% to 8%)7% (7% to 8%)1.03 (0.94 to 1.14) (0.49)
ILI10 569 (57)7946 (43)1.3320% (19% to 20%)19% (18%–20%)1.02 (0.96 to 1.09) (0.47)
ILI with comorbidity1951 (57)1468 (43)1.3325% (23% to 27%)29% (27% to 31%)0.87 (0.78 to 0.97) (0.02)
Impetigo5272 (64)2907 (36)1.8152% (51% to 54%)62% (60% to 63%)0.85 (0.81 to 0.88) (<0.001)
Impetigo with comorbidity1139 (66)598 (34)1.9054% (51% to 57%)63% (58% to 66%)0.86 (0.80 to 0.94) (<0.001)
LRTI52 996 (60)35 777 (40)1.4891% (91% to 92%)91% (91% to 91%)1.00 (1.00 to 1.01) (0.02)
LRTI with comorbidity36 693 (60)24 519 (40)1.5091% (90% to 91%)90% (89% to 90%)1.01 (1.01 to 1.02) (<0.001)
Otitis media11 773 (64)6545 (36)1.8084% (84% to 85%)84% (83% to 85%)1.00 (0.99 to 1.02) (0.58)
Otitis media with comorbidity2556 (65)1400 (35)1.8385% (84% to 87%)84% (82% to 86%)1.01 (0.98 to 1.04) (0.41)
Sinusitis46 221 (74)16 625 (26)2.7888% (88% to 89%)86% (86% to 87%)1.02 (1.02 to 1.03) (<0.001)
Sinusitis with comorbidity12 013 (73)4394 (27)2.7390% (90% to 91%)89% (88% to 90%)1.02 (1.00 to 1.03) (0.006)
Sore throat136 117 (68)65 531 (32)2.0857% (56% to 57%)57% (56%–57%)1.00 (0.99 to 1.01) (0.67)
Sore throat with comorbidity24 376 (67)11 968 (33)2.0453% (52% to 54%)50% (49% to 51%)1.06 (1.04 to 1.08) (<0.001)
URTI90 295 (68)42 998 (32)2.1034% (34% to 34%)36% (35% to 36%)0.96 (0.94 to 0.97) (<0.001)
URTI with comorbidity22 995 (65)12 515 (35)1.8445% (45% to 46%)45% (44% to 46%)1.00 (0.98 to 1.02) (0.96)
  • COPD, chronic obstructive pulmonary disease; ILI, influenza-like illness; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection.